Heart Failure Policy Summit 2024
The third international Heart Failure Policy Summit was held online on 9 and 11 April 2024
Find out more
European Heart Failure Mission
Driving political urgency in heart failure across the EU.
Find out more
Innovation: early diagnosis in community settings
This report focuses on early diagnosis of heart failure in community settings, identifying four key areas of innovation.
Find out more
heart graphic

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform of healthcare professionals, advocacy groups and policymakers from across Europe.

We aim to raise awareness of the unmet needs surrounding heart failure and its care, and to help drive meaningful changes in policy and practice.

Find out more
Latest
The Heart Failure Policy Summit returns in April 2024 to bring together heart failure advocates from across the world
18 January 2024

This April, the HFPN is delighted to host the Heart Failure Policy Summit 2024.

Read article
Latest
Five lessons from the European Heart Failure Mission launch event
15 November 2023

In October 2023, the HFPN launched the European Heart Failure Mission Statement at the European Parliament. Here’s five things we learned.

Read article
Latest
HFPN identifies six priority areas for future EU research into heart failure
27 October 2023

The HFPN has outlined six area which EU funding programmes should direct investments in heart failure research.

Read article
heart failure graphic
What is heart failure?

Affecting at least 15 million adults in Europe, heart failure is a common but complex clinical syndrome that occurs when the heart is unable to pump enough blood to meet body’s needs.

Its prevalence is expected to rise due to population ageing and improved survival rates for other long-term conditions, including cardiovascular diseases.

Find out more
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .